# PharmaCyte Biotech, Inc.: Form 8-K, filed Mar 9, 2022

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2022-03-09
- Accepted by EDGAR: Mar 9, 2022, 17:24 ET
- Period: 2022-03-07
- Accession: 0001683168-22-001550
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316822001550/pharmacyte_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316822001550/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316822001550/pharmacyte_8k.htm

Filed Mar 9, 2022.
Source: SEC EDGAR, the filing index for accession 0001683168-22-001550. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
